George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This is a Jan-23 article, but check that last paras about all the companies that have achieved gmp in uk:
https://businessofcannabis.com/uks-medical-cannabis-industry-enjoys-strong-start-to-2023/
Https://twitter.com/SkyNews/status/1725604722546028922?t=AlC4XblU6RmaMP1wRWdN2g&s=19
Thanks DJ. Excellent points. Just waiting for next buy signal then going to top up. Think this is a medium/long termer, that I'm hoping is going to give me my pension!
Another interesting point regarding the genetics programme and the potential for seed sales, she stated that this could be a standalone business. That would indicate a potentially significant revenue from the work stream in time.
Also, and whilst Melissa didn’t talk to these points from the slide, I thought it was noteworthy that we currently have capacity to produce 400,000 to 550,000 grams of dry flower (which equates too approx 0.5 tonnes) in the current facilities, but we have space to scale up-to 75 tonnes of dry flower! If my maths are correct that is approx 75m grams a year!
Given recent info from Melissa where she stated that to build the GMP it would likely cost £2-3m, it was encouraging to see that they are looking at a partnership agreement to fund this.
When discussing the competition slide, the key point here was that Ananda are looking to supply medication to treat conditions where there is currently no medication available, ie they are not looking to replace an incumbent supplier.
When it came to the questions, I felt Melissa didn’t duck any of mine and gave sound answers to every question that was asked.
I don’t know how well attended the IMC presentation was but hopefully it was sufficient to ensure this format will be repeated on a fairly regular basis.
I’ve just listened to the IMC presentation again. Here are my thoughts…
I had some reservations following the announcement to pause the genetics and growing trials programme and what that meant for the business, but this presentation has well and truly put my mind at ease.
Melissa very clearly presented the strategy to complete the genetics programme, to initiate commercial growing when the market was right, develop sales of seeds and deliver RCTs to give a gateway into the NHS for the MRX formulations.
I like the way they have pivoted the business such that funding for every work-stream is going to come from 3rd parties. Melissa’s very short response to my question about her confidence levels for securing funding for the genetics programme with Notts Trent Uni, ‘very confident’, makes me think it is already in the bag. Also, on more than one occasion Melissa commented how these funding routes would avoid further shareholder dilution, so she is clearly conscious of the impact of raises and loans over the last couple of years. I’m not saying this will be the end of fundraises, because I don’t think it will be, but hopefully we’ll see less in the short term than might have been expected.
I think what is significant for the 2 RCTs already announced is the calibre of the investigators who are running the trials. It is clear they are senior and very well respected individuals in their fields including Prof Andrew Horne who is Chairman of the World Endometriosis Congress, so will clearly have huge numbers of contacts which will be beneficial should the Endo RCT be successful.
When it came to more RCTs, I particularly like that there is a 2-way street developing, where Ananda are approaching clinicians but they are also approaching Ananda to use the MRX formulations for their patients. It was stated that they were in discussions with a range of researchers and universities and are building a pipeline of RCTs. I like how they have a stated aim of targeting stage II and III RCTs. My bet is that the next to be announced fairly soon will be for Fybromyalgia given Melissa’s comments.
For commercial growing I thought it was interesting how Melissa stated that commercial growing would not be dependent on completing the genetics programme. There is a clear desire to grow from Ananda’s own seeds but it was also clear that seeds from 3rd parties would be considered for commercial growing should be market be such that growing were to commence ahead of the completion of the genetics programme.
Also good to hear that the that the genetics programme would be started as quickly as possible and was not dependent on the 2024 growing season as the genetics programme was undertaken indoors and not in the tunnels.
To be doing what we are doing and knowledge and data being banked as a result all under 3rd party funding is a master class stroke I'd say,we have irons in the fire now and I really don't think it will be too long before people start to gather round to feel the warm within! After all we are getting as mentioned many approaches from authorities, clinicians fuelled by patients within with a solid need for progression to take the pain away be it endometriosis or neuropathic and I'm sure many more to add as the collaborations keep rolling in with more rct's! Certainly we are in pivotal times within a sector that's not going away
Pans out.
I also really enjoyed the presentation. I felt that Melissa padded things out, tackled questions head on and answered them evenly without sofsoaping or embellishing. Good things are on the horizon if this pays out, and frameworks are being fitted. The growing is only paused, not killed off. Patience for the sp, it is what it is at present. And the future is not just with Scottish NHS but UK wide, with Scotland being a really good base. They hope to be global some day.
All in all, a most enjoyable and informative listen imo! Thank you.
I'm not exactly sure what Gary is even doing here any more? Again, if you hate it so much, leave. People are hardly going to stop posting stuff that relates to the company on the company's own forum. And LSE is hardly going to allow a premium-registered 'Melissa Sturgess' to troll a forum that the real Melissa Sturgess can easily monitor and complain about if she feels her identity has been lifted and some rando is speaking on her behalf. Do you actually understand how the world works?
It's as if you're shocked that people have the temerity to post. You bring yourself here and then have tantrums with people, like you did in the Telegram group. If you're compelled to be like this all the time then that's on you, not other people.
I'm open to any company criticism as well as praise where due. I've also seen boiler roomers and trolls make various forums all about them, work in tag teams or packs, and try and distract and deviate from conversation about the company. This time you are the one blocked and so is that cuckoo fella. You're both a royal time-wasting miss imo. I won't be including either of you. Or just the one of you, in future mentions. And I suggest others do the same.
Well Gary was in the group but left, rejoined and left again because he didn’t like it when people challenged him in his sour demeanour.
Cookoo isn’t in the group either although I have suggested he should join to get a wider perspective.
However, there are over 70 members of the group, so you be joining a wider community than posts in here. Up to you.
Thanks Dj. May well do. If cuckoo and gazza are in there too, it'll be good to hear more of their investment insights.
Hello Gary! oh, sorry Cookoo! 🤣
First sign of madness djb is talking to /praising yourself
Good summary Pompey!
Not sure if you are already in the our Telegram group but feel free to join.
Enjoyed the presentation. Good to hear healthcare professionals are approaching Ana, as well as Ana reaching out. The drive to provide the NHS/NICE with an evidence base was good to hear, too, as well as initiatives including the data room and a planned increase in clinical trials. A question focussed on the disappointing share price performance. Aquis are supposed to be doing more to help in this area in the meantime, but I think patience was the watchword I took away from it.
Cookoo - You are sounding very much like Gary! 🤔
It’s a shame you didn’t listen as you might have learnt something and actually refound the reason for you investing in Ananda.
But given you didn’t because you are so embittered, just grow some balls, sell up, take the loss and put yourself out of the misery you are in!
Lord, imagine being this bitter and toxic about a company you choose to sniff around. Classic boiler room baiting. I thought it had died out with the parrots and barmen but apparently not.
No djb i am not an ar5e licker like some, post that to all your profiles to save me time
Cookoo - You are not happy with Ananda, so did you join the IMC and ask any questions?
Count Von Counts back.
Yep absolutely fantastic look at the hike in the sp ,nugget
I cheated and asked multiple questions in one submission! 😁
Looks that way. :)
Also getting, and keeping, away from this soul-destroying sp level will also be a welcome step up.